HMS
SCLN

Hanseatic Management Services’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Hanseatic Management Services’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-62
Closed -$1K – 372
2016
Q2 		$1K Buy
+62
New +$812 ﹤0.01% 306

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hanseatic Management Services's SCLN Position: Q3 2016 in Review

Hanseatic Management Services sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2016, closing a stake of 62 shares — an estimated $1K sold.

Hanseatic Management Services first reported a position in SCLN in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 151 funds tracked by Wall St. Rank hold SCLN as of Q3 2016.

  • Hanseatic Management Services reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Hanseatic Management Services sold 62 Sciclone Pharmaceuticals Inc shares in Q3 2016, an estimated $1K.
  • Hanseatic Management Services first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 1 quarter.
  • Hanseatic Management Services's Sciclone Pharmaceuticals Inc position peaked at $1K in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2016.

Based on Hanseatic Management Services's 13F filing for Q3 2016, filed 2 Nov 2016.